Cargando…

Impact of Dapagliflozin Therapy on Renal Protection and Kidney Morphology in Patients With Uncontrolled Type 2 Diabetes Mellitus

BACKGROUND: We examined whether the sodium-glucose cotransporter-2 inhibitor (SGLT2i) dapagliflozin can improve urine albumin-to-creatinine ratio (UACR) associated with a reduction in body weight or body fat in patients with type 2 diabetes mellitus (T2DM). METHODS: We prospectively recruited T2DM p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugiyama, Seigo, Jinnouchi, Hideaki, Kurinami, Noboru, Hieshima, Kunio, Yoshida, Akira, Jinnouchi, Katsunori, Tanaka, Motoko, Nishimura, Hiroyuki, Suzuki, Tomoko, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouchi, Tomio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916535/ https://www.ncbi.nlm.nih.gov/pubmed/29707088 http://dx.doi.org/10.14740/jocmr3419w

Ejemplares similares

The SGLT2 Inhibitor Dapagliflozin Significantly Improves the Peripheral Microvascular Endothelial Function in Patients with Uncontrolled Type 2 Diabetes Mellitus
por: Sugiyama, Seigo, et al.
Publicado: (2018)

Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes
por: Sugiyama, Seigo, et al.
Publicado: (2018)

Renoprotective Effects of Additional SGLT2 inhibitor Therapy in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3b-4: A Real World Report From A Japanese Specialized Diabetes Care Center
por: Sugiyama, Seigo, et al.
Publicado: (2019)

Initial Acute Decline in Estimated Glomerular Filtration Rate After Sodium-Glucose Cotransporter-2 Inhibitor in Patients With Chronic Kidney Disease
por: Sugiyama, Seigo, et al.
Publicado: (2020)

Liraglutide, a Glucagon-Like Peptide-1 Analog, Increased Insulin Sensitivity Assessed by Hyperinsulinemic-Euglycemic Clamp Examination in Patients with Uncontrolled Type 2 Diabetes Mellitus
por: Jinnouchi, Hideaki, et al.
Publicado: (2015)

Clinical Factors Associated with Initial Decrease in Body-Fat Percentage Induced by Add-on Sodium-Glucose Co-transporter 2 Inhibitors in Patient with Type 2 Diabetes Mellitus
por: Kurinami, Noboru, et al.
Publicado: (2017)

Smoking Cessation Ameliorates Microalbuminuria With Reduction of Blood Pressure and Pulse Rate in Patients With Already Diagnosed Diabetes Mellitus
por: Hieshima, Kunio, et al.
Publicado: (2018)

Elevation of the renal threshold for glucose is associated with insulin resistance and higher glycated hemoglobin levels
por: Hieshima, Kunio, et al.
Publicado: (2020)

Body Muscle-to-Fat Ratio, Rather Than Fat-to-Muscle Ratio, Significantly Correlates With Measured Insulin Resistance in Patients With Type 2 Diabetes Mellitus
por: Kurinami, Noboru, et al.
Publicado: (2021)

A pilot study of ezetimibe vs. atorvastatin for improving peripheral microvascular endothelial function in stable patients with type 2 diabetes mellitus
por: Sugiyama, Seigo, et al.
Publicado: (2015)

Reduced Number of Remaining or Healthy Teeth in Patients with Type 2 Diabetes Mellitus: A Cross-sectional Study Assessed by Dentists or Dental Hygienists in Japan
por: Kurinami, Noboru, et al.
Publicado: (2023)

Type 2 Diabetes Remission and Substantial Body Weight Reduction Achieved with Metformin and a Sodium-Glucose Cotransporter 2 Inhibitor
por: Sugiyama, Seigo, et al.
Publicado: (2020)

A Non-obese, Treatment-Naive Japanese Diabetic Patient With Elevated Insulin Clearance and Hyperglycemia Under Enhanced Insulin Sensitivity and Increased Insulin Secretion: Elevated Insulin Clearance as Type 2 Japanese Diabetes Mellitus (T2JDM)
por: Sugiyama, Seigo, et al.
Publicado: (2021)

Continuous Glucose Monitoring During Basal–Bolus Therapy Using Insulin Glargine 300 U mL(−1) and Glargine 100 U mL(−1) in Japanese People with Type 1 Diabetes Mellitus: A Crossover Pilot Study
por: Jinnouchi, Hideaki, et al.
Publicado: (2015)

The Authors Reply:
por: Kim-Mitsuyama, Shokei, et al.
Publicado: (2013)

An angiotensin II receptor blocker–calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone
por: Kim-Mitsuyama, Shokei, et al.
Publicado: (2013)

Combination Treatment of Rosuvastatin or Atorvastatin, with Regular Exercise Improves Arterial Wall Stiffness in Patients with Coronary Artery Disease
por: Toyama, Kensuke, et al.
Publicado: (2012)

Correction: Combination Treatment of Rosuvastatin or Atorvastatin, with Regular Exercise Improves Arterial Wall Stiffness in Patients with Coronary Artery Disease
por: Toyama, Kensuke, et al.
Publicado: (2013)

Association between aldehyde dehydrogenase 2 polymorphisms and the incidence of diabetic retinopathy among Japanese subjects with type 2 diabetes mellitus
por: Morita, Kazunori, et al.
Publicado: (2013)

Sex Differences in the Renal Function Decline of Patients with Type 2 Diabetes
por: Kajiwara, Ayami, et al.
Publicado: (2016)

Interactive effects of a common γ-glutamyltransferase 1 variant and low high-density lipoprotein-cholesterol on diabetic macro- and micro-angiopathy
por: Jinnouchi, Hideaki, et al.
Publicado: (2015)

Low-Dose Aspirin Therapy in Patients With Type 2 Diabetes and Reduced Glomerular Filtration Rate: Subanalysis from the JPAD trial
por: Saito, Yoshihiko, et al.
Publicado: (2011)

Improving diagnostic accuracy of 3 Screen ICA ELISA kit in the identification of Japanese type 1 diabetes
por: Kawasaki, Eiji, et al.
Publicado: (2023)

Detection of prostate cancer by an FDG-PET cancer screening program: results from a Japanese nationwide survey
por: Minamimoto, Ryogo, et al.
Publicado: (2014)

Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis
por: Jinnouchi, Hideaki, et al.
Publicado: (2020)

Incremental Prognostic Significance of the Elevated Levels of Pentraxin 3 in Patients With Heart Failure With Normal Left Ventricular Ejection Fraction
por: Matsubara, Junichi, et al.
Publicado: (2014)

Clinical Effectiveness and Impact on Insulin Therapy Cost After Addition of Dapagliflozin to Patients with Uncontrolled Type 2 Diabetes
por: Sosale, Bhavana, et al.
Publicado: (2016)

SUSY searches with the ATLAS detector
por: Jinnouchi, Osamu
Publicado: (2019)

Mono-jet searches
por: Jinnouchi, Osamu
Publicado: (2017)

SUSY searches with the ATLAS detector
por: Jinnouchi, Osamu
Publicado: (2018)

New physics searches at the LHC : Where do we go with run II
por: Jinnouchi, Osamu
Publicado: (2015)

Latest ATLAS Results on Higgs and BSM Physics
por: Jinnouchi, Osamu
Publicado: (2014)

Searches for BSM and Higgs boson at LHC
por: JINNOUCHI, O
Publicado: (2012)

SUSY physics with early data Understanding ATLAS detector and backgrounds
por: Jinnouchi, O
Publicado: (2006)

Searches for SUSY with the ATLAS detector
por: Jinnouchi, O
Publicado: (2009)

Searches for SUSY with the ATLAS detector
por: Jinnouchi, Osamu
Publicado: (2009)

Searches for BSM and Higgs boson at LHC
por: JINNOUCHI, O
Publicado: (2012)

Role of acetylcholine spasm provocation test as a pathophysiological assessment in nonobstructive coronary artery disease
por: Suzuki, Satoru, et al.
Publicado: (2020)

Postoperative Ketoacidosis With Hypoglycemia in a Nondiabetic Patient Taking Dapagliflozin for Heart Failure: A Case Report
por: Seki, Hiroyuki, et al.
Publicado: (2022)

Study on muon level-1 trigger scheme for TGC
por: Jinnouchi, O, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_46kne1tjh4rgl3sbk8nqpk18dp